Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Alternative medicine does not exist, biomedicine does not exist, there is only evidence-based medicine.

International journal of adolescent medicine and health

Ventegodt S, Greydanus DE, Merrick J.
PMID: 22191177
Int J Adolesc Med Health. 2011;23(3):153-5. doi: 10.1515/ijamh.2011.037.

No abstract available.

New Drugs Approved in 2019.

The American journal of medicine

Ebied AM, Patel KH, Cooper-DeHoff RM.
PMID: 32145207
Am J Med. 2020 Jun;133(6):675-678. doi: 10.1016/j.amjmed.2020.01.030. Epub 2020 Mar 05.

In 2019, the US Food and Drug Administration (FDA) approved 48 novel drugs. Thirty of the 48 (62.5%) novel drug approvals were reviewed and approved through an expedited review pathway while 20 of the 48 (41.7%) were approved for...

Pharmacology behind Common Drug Nephrotoxicities.

Clinical journal of the American Society of Nephrology : CJASN

Perazella MA.
PMID: 29622670
Clin J Am Soc Nephrol. 2018 Dec 07;13(12):1897-1908. doi: 10.2215/CJN.00150118. Epub 2018 Apr 05.

Patients are exposed to numerous prescribed and over-the-counter medications. Unfortunately, drugs remain a relatively common cause of acute and chronic kidney injury. A combination of factors including the innate nephrotoxicity of drugs, underlying patient characteristics that increase their risk...

FDA designations for therapeutics and their impact on drug development and regulatory review outcomes.

Clinical pharmacology and therapeutics

Kesselheim AS, Darrow JJ.
PMID: 25670381
Clin Pharmacol Ther. 2015 Jan;97(1):29-36. doi: 10.1002/cpt.1. Epub 2014 Dec 01.

New prescription drugs receive approval from the US Food and Drug Administration (FDA) based on tests establishing safety and adequate and well-controlled trials demonstrating "substantial evidence" of efficacy. However, a number of legislative and regulatory initiatives, the most recent...

Wise words.

Drug and therapeutics bulletin

[No authors listed]
PMID: 27932384
Drug Ther Bull. 2016 Dec;54(12):133. doi: 10.1136/dtb.2016.12.0439. Epub 2016 Dec 08.

No abstract available.

Pharmacovigilance on twitter? Mining tweets for adverse drug reactions.

AMIA ... Annual Symposium proceedings. AMIA Symposium

O'Connor K, Pimpalkhute P, Nikfarjam A, Ginn R, Smith KL, Gonzalez G.
PMID: 25954400
AMIA Annu Symp Proc. 2014 Nov 14;2014:924-33. eCollection 2014.

Recent research has shown that Twitter data analytics can have broad implications on public health research. However, its value for pharmacovigilance has been scantly studied - with health related forums and community support groups preferred for the task. We...

More than two-dozen prescription drug-based risk scores are available for risk adjustment: A systematic review.

Journal of clinical epidemiology

Mehta HB, Wang L, Malagaris I, Duan Y, Rosman L, Alexander GC.
PMID: 33838274
J Clin Epidemiol. 2021 Sep;137:113-125. doi: 10.1016/j.jclinepi.2021.03.029. Epub 2021 Apr 07.

OBJECTIVE: While several prescription drug-based risk indices have been developed, their design, performance, and application has not previously been synthesized.STUDY DESIGN AND SETTING: We searched Ovid MEDLINE, CINAHL and Embase from inception through March 3, 2020 and included studies...

The last mile: taking the final steps in preventing pediatric pharmaceutical poisonings.

The Journal of pediatrics

Budnitz DS, Lovegrove MC.
PMID: 22056349
J Pediatr. 2012 Feb;160(2):190-2. doi: 10.1016/j.jpeds.2011.09.020. Epub 2011 Nov 05.

No abstract available.

[Feasibility, in general practice, to give to the patients clear, loyal and appropriate information about the undesirable side effects of the medicines prescribed. EICLAT study].

La Revue du praticien

Arnould P, Raineri F, Hebbrecht G, Duhot D.
PMID: 22288353
Rev Prat. 2011 Dec;61(10):1394-9.

Drug prescription in general practice is present in 78 to 83% of consultations; practitioners must give to their patient clear loyal and appropriate information about the undesirable side effects of the medicines prescribed. The object of the EICLAT study...

Quality, efficacy, safety-it is not enough!.

European journal of clinical pharmacology

Garattini S.
PMID: 33687517
Eur J Clin Pharmacol. 2021 Sep;77(9):1425-1426. doi: 10.1007/s00228-021-03110-3. Epub 2021 Mar 09.

There is a need of comparative studies to understand the differences in term of efficacy and safety of drugs with different mechanisms of action but similar therapeutic indications. This requires changes in the European Legislation of criteria for drug...

Showing 1 to 10 of 10 entries